Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye!

被引：1
|
作者：
Maria, Alexandre T. J. [1 ]
Delmas, Clement [2 ]
Coustal, Cyrille [3 ]
Palassin, Pascale [4 ]
Roubille, Franoois [2 ,5 ,6 ]
机构：
[1] Montpellier Univ Hosp, St Eloi Hosp, Inst Regenerat Med & Biotherapy IRMB, Internal Med & Immunooncol MedI2O, Montpellier, France
[2] Montpellier Univ, INI CRT, INSERM, PhyMedExp,CNRS CHU,Cardiol Dept, Montpellier, France
[3] Montpellier Univ Hosp, Local Referral Ctr Rare Autoimmune Dis, Dept Internal Med, Multiorgan Dis, Montpellier, France
[4] Montpellier Univ Hosp, Reg Pharmacovigilance Ctr, Dept Med Pharmacol & Toxicol, Montpellier, France
[5] Cardiol Dept, Intens Cardiac Care Unit, Montpellier, France
[6] Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR 9214, F-34295 Montpellier 5, France
来源：
EUROPEAN JOURNAL OF CANCER | 2022年 / 177卷
关键词：
Myocarditis; Heart failure; Immune checkpoint blocker; Immune-related adverse events; Myocardial biopsy; Coronary angiogram;
D O I：
10.1016/j.ejca.2022.09.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：194 / 196
页数：3
相关论文
共 50 条
  • [41] Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis: A systematic review and meta-analysis
    Song, Wenhua
    Zhang, Nan
    Lv, Tonglian
    Zhao, Yang
    Li, Guangping
    Tse, Gary
    Liu, Tong
    CANCER INNOVATION, 2024, 3 (03):
  • [42] Cardiogenic shock secondary to immune checkpoint inhibitor associated myocarditis
    Lee, Kuan Ken
    Bain, Tanith
    Flapan, Andrew
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2024, 54 (03) : 225 - 230
  • [43] Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis
    Alessandro Inno
    Luigi Tarantini
    Iris Parrini
    Paolo Spallarossa
    Nicola Maurea
    Irma Bisceglia
    Nicola Silvestris
    Antonio Russo
    Stefania Gori
    Current Oncology Reports, 2023, 25 : 743 - 751
  • [44] A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma
    Shuichiro Iwasaki
    Hisashi Hidaka
    Haruki Uojima
    Miho Hashimura
    Takeru Nabeta
    Itaru Sanoyama
    Naohisa Wada
    Kousuke Kubota
    Takahide Nakazawa
    Akitaka Shibuya
    Wasaburo Koizumi
    Clinical Journal of Gastroenterology, 2021, 14 : 1233 - 1239
  • [45] Myocarditis associated with immune checkpoint inhibitor therapy: a case report of three patients
    Kianoush Ansari-Gilani
    Sree Harsha Tirumani
    Daniel A. Smith
    Ariel Nelson
    Asrar Alahmadi
    Christopher J. Hoimes
    Nikhil H. Ramaiya
    Emergency Radiology, 2020, 27 : 455 - 460
  • [46] Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
    Zhou, Yu-Wen
    Zhu, Ya-Juan
    Wang, Man-Ni
    Xie, Yao
    Chen, Chao-Yue
    Zhang, Tao
    Xia, Fan
    Ding, Zhen-Yu
    Liu, Ji-Yan
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [47] Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis
    Thakker, Ravi A.
    Lee, Marissa A.
    Albaeni, Aiham
    Elbadawi, Ayman
    Suthar, Krishna H.
    Perez, Christopher
    Sonstein, Lindsay K.
    Farr, Norman M.
    Venkatesan, Rohit
    Khalife, Wissam
    Berbarie, Rafic F.
    Chatila, Khaled F.
    CARDIOLOGY RESEARCH, 2021, 12 (05) : 270 - 278
  • [48] Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities
    Wu, Nan-Chun
    Feng, Yin-Hsun
    Kuo, Yu Hsuan
    Chen, Wei-Yu
    Wu, Hong-Chang
    Huang, Chien-Tai
    Wang, Wen-Ching
    Kang, Nai-Wen
    Shih, Jhih-Yuan
    Chen, Zhih-Cherng
    Chang, Wei-Ting
    ACTA CARDIOLOGICA SINICA, 2022, 38 (01) : 39 - 46
  • [49] Immune Checkpoint Inhibitor-Associated Myositis A Distinct Form of Inflammatory Myopathy
    Saygin, Didem
    Ghosh, Nilasha
    Reid, Pankti
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (07) : 367 - 373
  • [50] A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma
    Iwasaki, Shuichiro
    Hidaka, Hisashi
    Uojima, Haruki
    Hashimura, Miho
    Nabeta, Takeru
    Sanoyama, Itaru
    Wada, Naohisa
    Kubota, Kousuke
    Nakazawa, Takahide
    Shibuya, Akitaka
    Koizumi, Wasaburo
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (04) : 1233 - 1239
12345